Selected article for: "antiviral therapy and coronavirus infection"
Author: Wu, Chang-Jer; Chan, Yi-Lin
Title: Antiviral applications of RNAi for coronavirus
  • Cord-id: 1nau263l
  • Document date: 2006_1_24
    • ID: 1nau263l
    Snippet: Until the appearance of severe acute respiratory syndrome (SARS), caused by the SARS coronavirus (SARS-CoV) in early 2003, coronavirus infection was not considered to be serious enough to be controlled by either vaccination or specific antiviral therapy. It is now believed that the availability of antiviral drugs effective against SARS-CoV will be crucial for the control of future SARS outbreaks. Recently, RNA interference has been successfully used as a more specific and efficient method for ge
    Document: Until the appearance of severe acute respiratory syndrome (SARS), caused by the SARS coronavirus (SARS-CoV) in early 2003, coronavirus infection was not considered to be serious enough to be controlled by either vaccination or specific antiviral therapy. It is now believed that the availability of antiviral drugs effective against SARS-CoV will be crucial for the control of future SARS outbreaks. Recently, RNA interference has been successfully used as a more specific and efficient method for gene silencing. RNA interference induced by small interfering RNA can inhibit the expression of viral antigens and so provides a new approach to the therapy of pathogenic viruses. This review provides an overview of current information on coronavirus and the application of small interfering RNA in viral therapeutics, with particular reference to SARS-CoV.

    Search related documents:
    Co phrase search for related documents
    • activation step and acute respiratory syndrome: 1, 2, 3
    • acute respiratory syndrome and administration protocol: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory syndrome and long segment: 1
    • acute respiratory syndrome and lung lymphopenia: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15